Previous
Previous

In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

Next
Next

Targeting Metabolic Bottlenecks in Lung Cancer